Gainers
- Affimed N.V. (NASDAQ:AFMD) shares climbed 246.88 percent to close at $5.55 on Tuesday after the clinical stage biopharmaceutical company that focuses on cancer immunotherapies announced an encouraging update. The company said it signed a new strategic collaboration agreement with Genentech and will receive an upfront $96 million payment and up to an additional $5 billion over time.
- Asta Funding, Inc. (NASDAQ:ASFI) jumped 36.84 percent to close at $3.90 after the company updated its previously announced financial restatement. The company said that changes don't impact revenue and expense items or the consolidated balance sheet and statement of cash flows.
- Brooks Automation, Inc (NASDAQ:BRKS) climbed 30.91 percent to close at $39.60 after the company agreed to sell its semiconductor cryogenics business to Atlas Copco for $675 million in cash.
- ATA Inc. (NASDAQ:ATAI) gained 28.86 percent to close at $2.59 after surging 179.17 percent on Monday.
- DSW Inc. (NYSE:DSW) surged 20.22 percent to close at $32.70 after the company reported upbeat Q2 results and raised its FY18 forecast.
- Staffing 360 Solutions, Inc. (NASDAQ:STAF) shares climbed 19.69 percent to close at $2.31 after announcing the acquisition of Key Resources Inc. in North Carolina.
- Axsome Therapeutics, Inc. (NASDAQ:AXSM) gained 18.81 percent to close at $3.00.
- VivoPower International PLC (NASDAQ:VVPR) rose 17.83 percent to close at $1.85 following the closing of a AU$5 million debtor finance facility in Australia.
- Pixelworks, Inc. (NASDAQ:PXLW) gained 16.32 percent to close at $4.99.
- Ability Inc. (NASDAQ:ABIL) climbed 15.67 percent to close at $4.06 after declining 4.36 percent on Monday.
- Replimune Group, Inc. (NASDAQ:REPL) gained 14.58 percent to close at $19.25.
- Geron Corporation (NASDAQ:GERN) shares climbed 14.05 percent to close at $5.52.
- Bilibili Inc. (NASDAQ:BILI) rose 13.44 percent to close at $13.08 after reporting Q2 results.
- Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) shares rose 13.24 percent to close at $3.25 after gaining 2.14 percent on Monday.
- Sears Holdings Corporation (NASDAQ:SHLD) rose 12.61 percent to close at $1.25 after the company announced an expansion of its tire purchase and installation program.
- Evofem Biosciences, Inc. (NASDAQ:EVFM) gained 11.21 percent to close at $2.580.
- Heico Corp (NYSE:HEI) climbed 11.09 percent to close at $89.72 after the company reported stronger-than-expected earnings for its third quarter on Monday.
- Aclaris Therapeutics, Inc. (NASDAQ:ACRS) shares rose 10.85 percent to close at $15.94.
- Reata Pharmaceuticals, Inc. (NASDAQ:RETA) shares climbed 10.63 percent to close at $83.58 on Tuesday.
- Reed's, Inc. (NYSE:REED) gained 10.34 percent to close at $3.20.
- Genprex, Inc. (NASDAQ:GNPX) climbed 10.29 percent to close at $2.68.
- Kornit Digital Ltd. (NASDAQ:KRNT) rose 8.29 percent to close at $20.25.
- Coherus BioSciences, Inc. (NASDAQ:CHRS) gained 7.43 percent to close at $20.25. H.C. Wainwright initiated Coherus Biosciences with a Buy rating.
- Lattice Semiconductor Corporation (NASDAQ:LSCC) rose 6.23 percent to close at $8.02 after announcing the appointment of Jim Anderson as CEO.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Losers
- Akcea Therapeutics, Inc. (NASDAQ:AKCA) dipped 25.33 percent to close at $24.73 on Tuesday after the biopharmaceutical company that focuses on treating serious and rare diseases said the FDA rejected its New Drug Application for volanesorsen.
- Seven Stars Cloud Group, Inc. (NASDAQ:SSC) shares tumbled 18.18 percent to close at $4.05.
- Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) shares dropped 15.88 percent to close at $45.17 after the FDA issued a CRL on Volanesorsen.
- Mitek Systems, Inc. (NASDAQ:MITK) shares slipped 15.29 percent to close at $7.20 after the company announced management changes and reaffirmed in-line 2018 sales guidance.
- PDF Solutions, Inc. (NASDAQ:PDFS) declined 13.46 percent to close at $8.81.
- Lantronix, Inc. (NASDAQ:LTRX) dropped 12.42 percent to close at $5.50.
- Vaccinex, Inc. (NASDAQ:VCNX) shares fell 11.61 percent to close at $9.21 on Tuesday.
- Obalon Therapeutics, Inc. (NASDAQ:OBLN) fell 10.2 percent to close at $2.64.
- Arlo Technologies, Inc. (NYSE:ARLO) dipped 9.53 percent to close at $20.88 on Tuesday.
- Standex International Corporation (NYSE:SXI) shares dropped 8.85 percent to close at $103.55 following Q4 earnings.
- Cronos Group Inc. (NASDAQ:CRON) fell 7.97 percent to close at $11.08.
- Phibro Animal Health Corporation (NASDAQ:PAHC) dipped 7.94 percent to close at $49.25 following Q4 results.
- Control4 Corporation (NASDAQ:CTRL) fell 7.72 percent to close at $33.69. Imperial Capital downgraded Control4 from Outperform to In-Line.
- Sibanye Gold Limited (NYSE:SBGL) fell 7.66 percent to close at $2.29. Macquarie downgraded Sibanye Gold from Neutral to Underperform.
- Canopy Growth Corporation (NYSE:CGC) fell 6.74 percent to close at $43.20.
- Best Buy Co., Inc. (NYSE:BBY) shares fell 5.01 percent to close at $77.57. Best Buy posted upbeat results for its second quarter, but issued weak profit forecast for the current quarter.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.